Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
N Engl J Med
.
2018 Nov 29;379(22):2178.
doi: 10.1056/NEJMc1812500.
Authors
Hussein A Tawbi
1
2
,
Caroline Chung
1
,
Kim Margolin
3
Affiliations
1
University of Texas M.D. Anderson Cancer Center, Houston, TX
2
htawbi@mdanderson.org
3
City of Hope, Duarte, CA
PMID:
30485776
DOI:
10.1056/NEJMc1812500
No abstract available
Publication types
Letter
Comment
MeSH terms
Antibodies, Monoclonal
Brain
Humans
Ipilimumab*
Melanoma
Nivolumab*
Substances
Antibodies, Monoclonal
Ipilimumab
Nivolumab